Clinical Trial Update: Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating Botox for congenital muscular torticollis in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Muscular Torticollis

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of British Columbia | Conditions: Torticollis | Phase 1 | Status: WITHDRAWN